Listing Thumbnail

    Guardians of Health: Analyzing the Animal Vaccines Market (2024-2030)

     Info
    Deployed on AWS
    The global Animal Vaccines Market is projected to achieve a market size of USD 18.96 billion by 2030, experiencing a compound annual growth rate (CAGR) of 7.1% from 2024 to 2030. This growth is primarily attributed to several key factors, including the increasing reliance on animals for food production, a rise in pet adoption rates, and the imperative to combat antibiotic resistance in animals due to escalating bacterial content in their intestines.

    Overview

    The global Animal Vaccines Market size is expected to reach USD 18.96 billion by 2030, with a CAGR of 7.1% from 2024 to 2030. Animal vaccine is a kind of booster dose for providing immunity to the domestic & wild animals.

    Vaccines are the most cost-effective measures in preventing disease in livestock populations. It is formulated to build extra power in the immune system to fight future infections and disease-causing agents. It plays an important role in animal healthcare through prevention of various communicable diseases such as anthrax, black quarter (black-leg), and rabies (mad dog disease).

    Market Dynamics and Trends:

    Growing dependency of humans on animal for food production, rising pet adoption, and the need to increase antibiotic resistance among animals with growing bacteria content in their intestines are expected to drive the growth of the global animal vaccines market. Moreover, the growing demand for animal vaccines has led to the development of multiple new vaccines among various companies.

    Get a FREE report sample,here, https://www.nextmsc.com/animal-vaccines-market/request-sample 

    However, possibility of adverse impact of veterinary vaccines on animal health lack of animal health awareness among uneducated people, and high cost of vaccines are the factors that restrain the growth of the market. On the contrary, surge in investments in R&D activities of vaccines that inhibit the growth of antibiotic-resistant organisms are expected to create ample opportunities for the market in the coming years.

    Market Segmentations and Scope of the Study:

    The global animal vaccines market share is segmented on the basis of product, animal type, route of administration, vaccine type, and geography. On the basis of product, the market is categorized into DNA vaccines, inactivated vaccines, toxoid vaccines, subunit vaccines, attenuated vaccines, conjugate vaccines, and recombinant vaccines. On the basis of animal type, the market is divided into livestock animal and companion animal.

    Geographical Analysis:

    North America holds the major share of the animal vaccines market at present and is expected to continue its dominance during the forecast period. This is attributed to factors such as increase in adoption of pet animals and rise in zoonotic diseases such as plague,rabies, and brucellosis that can negatively impact human lives. The number of organizations such as North Shore Animal League America, The American Humane Society and The Humane Society of the United States (HSUS) are focused on the safety and well-being of animals.

    Access the full report,here, https://www.nextmsc.com/report/animal-vaccines-market 

    Moreover, the introduction of third generation vaccine that includes DNA, RNA, and recombinant viral-vector vaccines is helpful in prevention of infections in animals. The companies that are involved in the production of these vaccines are Neogen Corporation and Dechra Pharmaceuticals. All the above-mentioned factors are expected to propel the market growth in this region.

    Moreover, Asia-pacific is expected to show a steady rise in the market due to rising awareness of food security as people are dependent on animals for poultry farming in this region and rising canine disorder such as rabies, distemper, and hepatitis which leads to the demand of vaccines as it will lower the risk of infection in the bodies of animal.

    Also, environmental degradation leading to imbalanced biodiversity along with growing pollution and climate change adversely affect the animal health. These factors can cause immune suppression, oxidative stress, and metabolic disruptions in animals. They may also lead to infections and death among animals. These factors increase the demand for animal vaccines, and are expected to drive the animal vaccines market growth in this region.

    Competitive Landscape:

    Key market players of the global animal vaccines market include Ceva Sante Animale, Boehringer Ingelheim Animal Health, Durvet, Inc., Dechra Pharmaceuticals., Henry Schein Animal Health, Elanco, Merck Animal Health, Hipra Animal Health Limited, Zoetis, and Neogen Corporation. These market players are adopting various strategies such as acquisitions and new product launches to maintain their dominance in the global animal vaccine market.

    Details

    Delivery method

    Deployed on AWS
    New

    Introducing multi-product solutions

    You can now purchase comprehensive solutions tailored to use cases and industries.

    Multi-product solutions

    Features and programs

    Financing for AWS Marketplace purchases

    AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
    Financing for AWS Marketplace purchases

    Pricing

    Guardians of Health: Analyzing the Animal Vaccines Market (2024-2030)

     Info
    This product is available free of charge. Free subscriptions have no end date and may be canceled any time.
    Additional AWS infrastructure costs may apply. Use the AWS Pricing Calculator  to estimate your infrastructure costs.

    Vendor refund policy

    Not applicable - product available free of charge.

    How can we make this page better?

    We'd like to hear your feedback and ideas on how to improve this page.
    We'd like to hear your feedback and ideas on how to improve this page.

    Legal

    Vendor terms and conditions

    Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA) .

    Content disclaimer

    Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.

    Usage information

     Info

    Delivery details

    AWS Data Exchange (ADX)

    AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.

    Additional details

    Data sets (1)

     Info

    You will receive access to the following data sets.

    Data set name
    Type
    Historical revisions
    Future revisions
    Sensitive information
    Data dictionaries
    Data samples
    NMSC_MarketResearch
    All historical revisions
    All future revisions
    Not included
    Not included

    Resources

    Vendor resources

    Similar products